Artificial Intelligence

From Idea to Approval: How Chelonia Builds Horizon Europe Projects That Deliver Impact Designing a successful Horizon Europe project is...

Bringing Together Regulators, Pharma, and Scientific Leaders to Shape the Future of Antiviral Strategies AVITHRAPID, the cutting-edge...

Presentation of Boltz-1 at MIT The MIT Jameel Clinic for Machine Learning in Health has unveiled Boltz-1 , a groundbreaking AI model...

In a recent survey published on the preprint server arXiv, researchers have brought to light a significant challenge faced by academic...

The pharmaceutical industry is on the brink of a transformative change, thanks to the advent of generative artificial intelligence (AI)....

Introduction: In the ever-evolving landscape of drug discovery and computational biology, the LIGATE project stands out for its...

The fusion of data science with drug development is reshaping the pharmaceutical industry. Here's an insightful exploration into how data...

At Chelonia, we are committed to advancing technology while upholding ethical standards. Our mission aligns with the complex challenges...

The Dawn of Artificial Intelligence in Investment Artificial Intelligence (AI) is rapidly emerging as a transformative force in various...

We are excited to present AiChemist, an innovative project backed by Horizon Europe and SERI. AiChemist stands at the forefront of...

At Chelonia, we are thrilled to announce our partnership with SAS, a global leader in data analytics. This collaboration marks a pivotal...

Chelonia, in collaboration with international partners, has recently submitted a groundbreaking project proposal to the European...

In the fast-paced world of medical advancements, drug repurposing has emerged as a groundbreaking strategy, offering a beacon of hope in...